Company Activities Contact Intranet Physicians Patients Families Veterinarians News & events Careers Results online Pay
en
EN FR DE

COVID-19 Serology

SEROLOGY TESTING FOR COVID-19

AFTER AN INFECTION, VACCINATION
OR A POTENTIAL EXPOSURE TO COVID-19

Click here to download our request form.

FOR TRAVELLING:
SEROLOGY TESTING FOR COVID-19

Please note that it does not replace a vaccine passport.

Click here to download our request form.

COVID-19 serologic testing

Detection of antibodies targeted against SARS-CoV-2

Serology testing aims at:

  • Detecting the persons who may have been exposed to the virus and then developed an immune response.
  • Assessing the immune response after vaccination.

To find out about an individual `s immunologic status

  • After vaccination
  • After an infection with COVID-19 or
  • After a potential exposure to COVID-19

Antibodies testing is performed using Roche assay SARS-CoV-2 (spike protein) IgG/IgM total antibody test.
Price: 35 euros

For those who must travel abroad:

We use the DiaSorin test to detect IgG and IgM antibodies against SARS-CoV-2 (COVID-19).
Some countries require that both results are indicated on the report of the serological testing.
Price: 39 euros

Tests conditions:

  •  NO medical prescription is required. Detection of antibodies targeted against COVID-19 can be performed WITH or WITHOUT a medical prescription (ordonnance) and WITHOUT an appointment in our blood withdrawal centers.
  • Specimen sample: A blood sample (1 dry tube) is required for serology testing.
  • The costs for serology testing are not covered by the CNS.

We would like to remind you that:

 So far, serology tests will not allow to determine how contagious those individuals are likely to be.

  • The kinetics of antibody production against the virus is not well defined yet, especially in asymptomatic people.
  • The time period of a possible immunity is also unclear.

These applications and recommendations will be regularly updated according to the rapidly evolving knowledge on COVID-19 and to the governmental recommendations.